Dietary fatty acids in the secondary prevention of coronary heart disease: a systematic review, meta-analysis and meta-regression
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Objective: Previous systematic reviews were not restricted to either primary or secondary prevention trials, this study aimed to investigate the effects of reduced and/or modified fat diets and dietary fatty acids on all-cause mortality, cardiovascular mortality and cardiovascular events in participants with established coronary heart disease. Design: Systematic review, meta-analysis and univariate/multivariate meta-regression. Eligibility and criteria for selecting studies: Electronic searches for randomised controlled trials comparing reduced/modified fat diets versus control diets were performed in MEDLINE, EMBASE and the Cochrane Library. Data extraction: Pooled effects were calculated using an inverse-variance random effect meta-analysis. Random effects univariate and multivariate meta-regressions were performed including changes in all types of dietary fatty acids. Results: Overall, 12 studies enrolling 7150 participants were included in the present systematic review. No significant risk reduction could be observed considering all-cause mortality (relative risk (RR) 0.92, p=0.60; I 2 =59%) and cardiovascular mortality (RR 0.96, p=0.84; I 2 =69%), combined cardiovascular events (RR 0.85, p=0.30; I 2 =75%) and myocardial infarction (RR 0.76, p=0.13; I 2 =55%) comparing modified fat diets versus control diets. This results could be confirmed for the reduced fat versus control diets (RR 0.79, p=0.47; I 2 =0%), (RR 0.93, p=0.66; I 2 =0%), (RR 0.93, p=0.71; I 2 =57%) and (RR 1.18, p=0.26; I 2 =18%). The multivariate and univariate model showed no significant associations between the independent variables and the changes from saturated fat, monounsaturated fat, polyunsaturated fat and linoleic acid. Sensitivity analyses did not reveal a significant risk reduction for any outcome parameter when polyunsaturated fat was increased in exchange for saturated fat. Conclusions: The present systematic review provides no evidence (moderate quality evidence) for the beneficial effects of reduced/modified fat diets in the secondary prevention of coronary heart disease. Recommending higher intakes of polyunsaturated fatty acids in replacement of saturated fatty acids was not associated with risk reduction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Mensink, R. P., Zock, P. L., Kester, A. D., & Katan, M. B. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.5.1146 · Cited by 2,811 · cited 1×
“Exchanging SFA for polyunsaturated fatty acids (PUFA), monounsaturated fatty acids (MUFA), carbohydrates (CHO) or protein exerted different effects on blood lipids and lipoproteins.(5) In a systematic review and meta-analysis of cohort studies and randomised controlled trials (RCTs), Skeaff and Miller(6) concluded tha…”
Lichtenstein, A. H., Appel, L. J., Brands, M., Carnethon, M., Daniels, S., Franch, H. A., Franklin, B., Kris-Etherton, P., Harris, W. S., Howard, B., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.176158 · Cited by 2,705
Burr, M. L., Gilbert, J. F., Holliday, R. M., Elwood, P. C., Fehily, A. M., Rogers, S., Sweetnam, P. M., & Deadman, N. M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90828-3 · Cited by 2,610
Can lifestyle changes reverse coronary heart disease?
Ornish, D., Brown, S. E., Billings, J. H., Scherwitz, L. W., Armstrong, W. T., Ports, T. A., McLanahan, S. M., Kirkeeide, R. L., Gould, K. L., & Brand, R. J. (1990) · The Lancet · doi:10.1016/0140-6736(90)91656-u · Cited by 2,338
THE DIET AND 15-YEAR DEATH RATE IN THE SEVEN COUNTRIES STUDY
KEYS, A., MIENOTTI, A., KARVONEN, M. J., ARAVANIS, C., BLACKBURN, H., BUZINA, R., DJORDJEVIC, B. S., DONTAS, A. S., FIDANZA, F., KEYS, M. H., et al. (1986) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114480 · Cited by 1,790 · cited 1×
“…these fi ndings established a reduction of SFA consumption as a major focus of dietary recommendations in order to prevent the prevalence of CHD 3 although Siri-Tarino et al 4 observed no relationship between saturated fats and CHD, stroke and cardiovascular disease (CVD) following a…”
Smith, S. C., Benjamin, E. J., Bonow, R. O., Braun, L. T., Creager, M. A., Franklin, B. A., Gibbons, R. J., Grundy, S. M., Hiratzka, L. F., Jones, D. W., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318235eb4d · Cited by 1,759 · cited 2×
“Although pharmaceutical treatment via lipid-lowering medications is considered to be an effective therapeutic measure for patients with established CVD, many international authorities recommend modifications of fat intake with a special emphasis on SFA as well.(13) 49 50 The current AHA/ACC guidelines promote to reduc…”
Mente, A., de Koning, L., Shannon, H. S., & Anand, S. S. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.38 · Cited by 1,267
Siri-Tarino, P. W., Sun, Q., Hu, F. B., & Krauss, R. M. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.27725 · Cited by 1,253 · cited 2×
“1 2 Supported by the epidemiological data observing a correlation between SFA intake and coronary heart disease (CHD) mortality, these fi ndings established a reduction of SFA consumption as a major focus of dietary recommendations in order to prevent the prevalence of CHD 3 although Siri-Tarino et al 4 observed no rel…”
Mozaffarian, D., Micha, R., & Wallace, S. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000252 · Cited by 1,215
Howard, B. V., Van Horn, L., Hsia, J., Manson, J. E., Stefanick, M. L., Wassertheil-Smoller, S., Kuller, L. H., LaCroix, A. Z., Langer, R. D., Lasser, N. L., et al. (2006) · JAMA · doi:10.1001/jama.295.6.655 · Cited by 1,091
Jakobsen, M. U., O’Reilly, E. J., Heitmann, B. L., Pereira, M. A., Bälter, K., Fraser, G. E., Goldbourt, U., Hallmans, G., Knekt, P., Liu, S., et al. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.27124 · Cited by 1,026 · cited 2×
“Furthermore, a review of 16 meta-analyses indicated that a diet rich in MUFA has several bene fi cial effects on a broad range of CVD risk factors, in the primary prevention of CVD. 48 In contrast to the data presented in this systematic review, a recent meta-analysis of observational studies suggests that replacing SF…”
Haskell, W. L., Alderman, E. L., Fair, J. M., Maron, D. J., Mackey, S. F., Superko, H. R., Williams, P. T., Johnstone, I. M., Champagne, M. A., & Krauss, R. M. (1994) · Circulation · doi:10.1161/01.cir.89.3.975 · Cited by 884
Singh, R. B., Dubnov, G., Niaz, M. A., Ghosh, S., Singh, R., Rastogi, S. S., Manor, O., Pella, D., & Berry, E. M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11472-3 · Cited by 663 · cited 4×
“In this systematic review of 7150 participants with established CHD or CAD comparing reduced and/or modi-fi ed fat diets versus control diets, no signi fi cant risk reduction (moderate quality of evidence) for all-cause mortality, cardiovascular mortality, cardiovascular events and myocardial infarction could be observe…”
InfluentialRamsden, C. E., Zamora, D., Leelarthaepin, B., Majchrzak-Hong, S. F., Faurot, K. R., Suchindran, C. M., Ringel, A., Davis, J. M., & Hibbeln, J. R. (2013) · BMJ · doi:10.1136/bmj.e8707 · Cited by 523
CONTROLLED TRIAL OF SOYA-BEAN OIL IN MYOCARDIAL INFARCTION
(1968) · The Lancet · doi:10.1016/s0140-6736(68)90746-0 · Cited by 476
Skeaff, C. M., & Miller, J. (2009) · Annals of Nutrition and Metabolism · doi:10.1159/000229002 · Cited by 310 · cited 2×
“In contrast, pooling RCTs indicated that a 5% increase in PUFA intake was associated with a significant reduction in CHD events.(6) Mente et al(47) observed a”
Corn Oil in Treatment of Ischaemic Heart Disease
Rose, G. A., Thomson, W. B., & Williams, R. T. (1965) · BMJ · doi:10.1136/bmj.1.5449.1531 · Cited by 197
Cited by
Dehghan, M., Mente, A., Zhang, X., Swaminathan, S., Li, W., Mohan, V., Iqbal, R., Kumar, R., Wentzel-Viljoen, E., Rosengren, A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32252-3 · Cited by 1,101
The relation of saturated fatty acids with low-grade inflammation and cardiovascular disease
Ruiz-Núñez, B., Dijck-Brouwer, D. A. J., & Muskiet, F. A. J. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.12.007 · Cited by 245
Red meat, diseases, and healthy alternatives: A critical review
Ekmekcioglu, C., Wallner, P., Kundi, M., Weisz, U., Haas, W., & Hutter, H.-P. (2018) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2016.1158148 · Cited by 173
A Scoping Review of Current Guidelines on Dietary Fat and Fat Quality
Schwingshackl, L., Zähringer, J., Beyerbach, J., Werner, S. S., Nagavci, B., Heseker, H., Koletzko, B., Meerpohl, J. J., & on behalf of the International Union of Nutritional Sciences (IUNS) Task force on Dietary Fat Quality (2021) · Annals of Nutrition and Metabolism · doi:10.1159/000515671 · Cited by 53
Self-citation
Metadata
- Authors
- Schwingshackl, L., & Hoffmann, G.
- Venue
- BMJ Open
- Publisher
- BMJ
- Published
- 2014-04
- Volume
- 4
- Issue
- 4
- Pages
- e004487
- ISSN
- 2044-6055 (ISSN-L)
- OpenAlex
- W2109132449
- Cited by
- 89
- References
- 18
- FWCI
- 1.38
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.